300,000 shares of ONCX at a cost basis average of .02 is $6,000.
With a historical ONCX bottom of roughly .01, the potential loss would be around $3,000.
300,000 shares that bounce to the previous high of $.20 would be $60,000.
With the conservative target price of .50, if FDA results are positive, would result in 300,000 ONCX shares being worth $150,000.
How many times have we discussed risk/reward ratios on the ONCX board?
I actually enjoy the ONCX debate and jibber/jabber.
Seriously though, we are looking at a $3,000 VAR against a potential $140,000 ROI.
Investors will probably not see odds like this again anytime soon on any OTC stock and it is shocking that people continue to squander this opportunity.